DNA Interstrand Cross-Linking Agents and their Chemotherapeutic Potential

Author(s): L. Brulikova, J. Hlavac, P. Hradil

Journal Name: Current Medicinal Chemistry

Volume 19 , Issue 3 , 2012

Become EABM
Become Reviewer
Call for Editor


DNA interstrand cross-linking (ICL) agents are an important group of cytotoxic drugs with the capability of binding covalently between two strands of DNA, thereby preventing vital processes such as replication or transcription in dividing cells. In anticancer therapy however, their potential is limited due to the resistance by various mechanisms. In order to develop highly effective antitumor drugs it is necessary to study both effective ICL formations and their subsequent repair mechanisms. This review presents an overview of development over the past decade and the use of both well-known and new DNA interstrand cross-linking agents. Their potential in applications especially as anticancer chemotherapeutics in the framework of current knowledge of repair mechanisms and development of combined chemotherapy is discussed

Keywords: Chemotherapy, cytotoxicity, DNA, interstrand cross-link, ICL, repair, resistance, anticancer, cytotoxic drugs, antitumor drugs

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2012
Page: [364 - 385]
Pages: 22
DOI: 10.2174/092986712803414295
Price: $65

Article Metrics

PDF: 69